A detailed history of Black Rock Inc. transactions in Cure Vac N.V. stock. As of the latest transaction made, Black Rock Inc. holds 2,253,769 shares of CVAC stock, worth $6.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,253,769
Previous 1,974,954 14.12%
Holding current value
$6.2 Million
Previous $5.98 Million 28.04%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$2.31 - $4.99 $644,062 - $1.39 Million
278,815 Added 14.12%
2,253,769 $7.66 Million
Q1 2024

May 10, 2024

BUY
$2.94 - $4.34 $497,912 - $735,013
169,358 Added 9.38%
1,974,954 $5.98 Million
Q4 2023

Feb 13, 2024

SELL
$3.96 - $6.41 $67,058 - $108,546
-16,934 Reduced 0.93%
1,805,596 $7.6 Million
Q3 2023

Nov 13, 2023

SELL
$6.5 - $10.77 $135,486 - $224,489
-20,844 Reduced 1.13%
1,822,530 $12.4 Million
Q2 2023

Aug 11, 2023

SELL
$6.69 - $12.25 $866,776 - $1.59 Million
-129,563 Reduced 6.57%
1,843,374 $19.2 Million
Q1 2023

May 12, 2023

BUY
$6.38 - $12.5 $4.86 Million - $9.51 Million
761,024 Added 62.8%
1,972,937 $13.8 Million
Q4 2022

Feb 13, 2023

BUY
$5.75 - $8.5 $1.37 Million - $2.02 Million
237,530 Added 24.38%
1,211,913 $7.31 Million
Q3 2022

Nov 14, 2022

SELL
$7.48 - $15.24 $569,415 - $1.16 Million
-76,125 Reduced 7.25%
974,383 $7.68 Million
Q2 2022

Aug 12, 2022

SELL
$13.18 - $19.41 $11.4 Million - $16.8 Million
-865,040 Reduced 45.16%
1,050,508 $14.3 Million
Q1 2022

May 12, 2022

BUY
$14.73 - $35.25 $1.64 Million - $3.93 Million
111,590 Added 6.19%
1,915,548 $37.6 Million
Q4 2021

Feb 10, 2022

BUY
$33.72 - $48.22 $23.3 Million - $33.4 Million
692,463 Added 62.3%
1,803,958 $61.9 Million
Q3 2021

Nov 09, 2021

BUY
$49.26 - $74.5 $2.69 Million - $4.07 Million
54,634 Added 5.17%
1,111,495 $60.7 Million
Q2 2021

Aug 11, 2021

BUY
$56.91 - $127.53 $60.1 Million - $135 Million
1,056,861 New
1,056,861 $77.7 Million

Others Institutions Holding CVAC

About CureVac N.V.


  • Ticker CVAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,467,008
  • Market Cap $516M
  • Description
  • CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...
More about CVAC
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.